The detection described that EZH2 negatively regulates TPM1 expression, and further results validated that EZH2 blocks TPM1 to promote CRC cell proliferation, and EZH2 knockdown on TPM1 to promote angiopoiesis were further confirmed by tube formation and scratch assays. This evidence concerns the gene EZH2 and colorectal carcinoma.